Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Devices and Getinge have recently announced their partnership under which they will integrate Getinge’s bioreactors with 908 ...
Trinity Biotech (TRIB) announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance ...
Diabetes device expert Steph Habif said her family's experiment with CGMs shows a big opportunity for wearables: intermittent ...
Shanghai researchers have devised a revolutionary, non-invasive method to monitor blood glucose, allowing for accurate blood ...
How does the body regulate the activity of insulin-producing cells in order to react quickly to changing conditions? Researchers have investigated this question.
Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...
Glucose monitoring has evolved beyond its traditional role in diabetes management, with an increasing number of people using ...
New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback